The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA.

TitleLung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA.
Publication TypeJournal Article
Year of Publication2020
AuthorsZarogoulidis, P., Petridis D., Sapalidis K., Tsakiridis K., Baka S., Vagionas A., Hohenforst-Schmidt W., Freitag L., Huang H., Bai C., Drougas D., Theofilatou V., Romanidis K., Perdikouri E-I., Petanidis S., Zaric B., Kovacevic T., Stojsic V., Sarcev T., Bursac D., Kukic B., Perin B., Courcoutsakis N., Athanasiou E., Hatzibougias D., Drevelegas K., Boukovinas I., Kosmidou M., & Kosmidis C.
JournalJ Cancer
Volume11
Issue21
Pagination6454-6459
Date Published2020
ISSN1837-9664
Abstract

Novel technologies are currently used for lung cancer diagnosis. EBUS-TBNA 22G is considered one of the most important tools. However; there are still issues with the sample size. 223 patients underwent EBUS-TBNA with a 21G Olympus needle, 22GUS Mediglobe and 22GUB Mediglobe. In order to evaluate the efficiency of 22GUB novel needle design. In order to evaluate the sample size of each needle, we constructed cell blocks and measured the different number of slices from each biopsy site. The 22GUB novel needle had similar and larger number of slices from each biopsy site compared to 21G needle. Firstly as a novel methodology we used the number of slices from the constructed cell blocks in order to evaluate the sample size. Secondly, we should seek novel needle designs and not only concentrate on the volume of the sample size.

DOI10.7150/jca.48691
Alternate JournalJ Cancer
PubMed ID33033529
PubMed Central IDPMC7532516

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.